KardiaMobile for detecting atrial fibrillation (HTG606)Product type:GuidanceProgramme:HealthTech guidanceLast updated: 25 July 2023Published: 6 January 2022
TYRX Absorbable Antibacterial Envelope for preventing infection from cardiac implantable electronic devices (terminated appraisal) (TA790)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 25 May 2022
ENDURALIFE powered CRT-D devices for treating heart failure (HTG433)Product type:GuidanceProgramme:HealthTech guidanceLast updated: 21 July 2021Published: 17 March 2017
Apixaban for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation (TA275)Product type:GuidanceProgramme:Technology appraisal guidanceLast updated: 2 July 2021Published: 27 February 2013
Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation (TA249)Product type:GuidanceProgramme:Technology appraisal guidanceLast updated: 2 July 2021Published: 15 March 2012
Edoxaban for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation (TA355)Product type:GuidanceProgramme:Technology appraisal guidanceLast updated: 2 July 2021Published: 23 September 2015
Rivaroxaban for the prevention of stroke and systemic embolism in people with atrial fibrillation (TA256)Product type:GuidanceProgramme:Technology appraisal guidanceLast updated: 2 July 2021Published: 23 May 2012
Atrial fibrillation: diagnosis and management (NG196)Product type:GuidanceProgramme:NICE guidelineLast updated: 30 June 2021Published: 27 April 2021
Vernakalant for the rapid conversion of recent onset atrial fibrillation to sinus rhythm (terminated appraisal) (TA675)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 17 February 2021
Zio XT for detecting cardiac arrhythmias (HTG562)Product type:GuidanceProgramme:HealthTech guidancePublished: 1 December 2020
Implantable cardiac monitors to detect atrial fibrillation after cryptogenic stroke (HTG553)Product type:GuidanceProgramme:HealthTech guidancePublished: 2 September 2020
Lead-I ECG devices for detecting symptomatic atrial fibrillation using single time point testing in primary care (HTG508)Product type:GuidanceProgramme:HealthTech guidancePublished: 8 May 2019
Atrial fibrillation and heart valve disease: self-monitoring coagulation status using point-of-care coagulometers (the CoaguChek XS system) (HTG353)Product type:GuidanceProgramme:HealthTech guidanceLast updated: 19 December 2017Published: 24 September 2014
Dual‑chamber pacemakers for symptomatic bradycardia due to sick sinus syndrome without atrioventricular block (TA324)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 26 November 2014
Dual‑chamber pacemakers for symptomatic bradycardia due to sick sinus syndrome and/or atrioventricular block (TA88)Product type:GuidanceProgramme:Technology appraisal guidanceLast updated: 1 November 2014Published: 23 February 2005
Implantable cardioverter defibrillators and cardiac resynchronisation therapy for arrhythmias and heart failure (TA314)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 25 June 2014
Dronedarone for the treatment of non-permanent atrial fibrillation (TA197)Product type:GuidanceProgramme:Technology appraisal guidanceLast updated: 1 December 2012Published: 25 August 2010